메뉴 건너뛰기




Volumn 58, Issue 12, 2009, Pages 1579-1581

HIV/hepatitis C co-infection and hepatic fibrosis: Looking beyond HIV-associated immune suppression; the contribution of hepatic steatosis and insulin resistance

(1)  Bhagani, Sanjay a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTEGRASE INHIBITOR; PEGINTERFERON ALPHA; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; THYMIDINE; ZIDOVUDINE;

EID: 72549093150     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.184473     Document Type: Note
Times cited : (3)

References (25)
  • 1
    • 30144437514 scopus 로고    scopus 로고
    • Epidemiology of viral hepatitis and HIV co-infection
    • Alter J. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006;44(Suppl 1):56-59
    • (2006) J Hepatol , vol.44 , Issue.SUPPL. 1 , pp. 56-59
    • Alter, J.1
  • 2
    • 85062055676 scopus 로고    scopus 로고
    • Liver-related deaths in persons infected with the human immunodeficiency virus
    • The Data Collection on Adverse Events of Anti-HIV Study Group.
    • The Data Collection on Adverse Events of Anti-HIV Study Group. Liver-related deaths in persons infected with the human immunodeficiency virus. Arch Intern Med 2006;166:1632-1641
    • (2006) Arch Intern Med , vol.166 , pp. 1632-1641
  • 3
    • 0038798716 scopus 로고    scopus 로고
    • Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients
    • DOI 10.1136/gut.52.7.1035
    • Mohsen AH, Easterbrook P, Taylor C, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003;52:1035-1040 (Pubitemid 36765298)
    • (2003) Gut , vol.52 , Issue.7 , pp. 1035-1040
    • Mohsen, A.H.1    Easterbrook, P.J.2    Taylor, C.3    Portmann, B.4    Kulasegaram, R.5    Murad, S.6    Wiselka, M.7    Norris, S.8
  • 4
    • 72549113119 scopus 로고    scopus 로고
    • Hepatitis C virus coinfection does not influence influence the CD4 cell recovery in HIV-1 infected patients with maximal viral suppression
    • Peters L, Morcroft A, Soriano V, et al. Hepatitis C virus coinfection does not influence influence the CD4 cell recovery in HIV-1 infected patients with maximal viral suppression. J Acquir Immune Defic Syndr 2003;33:577-584
    • (2003) J Acquir Immune Defic Syndr , vol.33 , pp. 577-584
    • Peters, L.1    Morcroft, A.2    Soriano, V.3
  • 5
    • 58149520605 scopus 로고    scopus 로고
    • Differences in virological response to pegylated interferon and ribavirin between hepatitis C (HCV)-monoinfected and HIV-HCV coinfected patients
    • Tural C, Galeras JA, Planas R, et al. Differences in virological response to pegylated interferon and ribavirin between hepatitis C (HCV)-monoinfected and HIV-HCV coinfected patients. Antiviral Therapy 2008;13:1047-1055
    • (2008) Antiviral Therapy , vol.13 , pp. 1047-1055
    • Tural, C.1    Galeras, J.A.2    Planas, R.3
  • 6
    • 35648952231 scopus 로고    scopus 로고
    • HCV-HIV coinfection: Simple messages from a complex disease
    • DOI 10.1371/journal.pmed.0040240
    • Klenerman P, Kim A. HCV-HIV coinfection: simple messages from a complex disease. PLOS Med 2007;4:e240. doi:10.1371/journal.pmed.0040240. (Pubitemid 350035450)
    • (2007) PLoS Medicine , vol.4 , Issue.10 , pp. 1608-1614
    • Klenerman, P.1    Kim, A.2
  • 7
    • 41549090888 scopus 로고    scopus 로고
    • HCV/HIV co-infection: Time to re-evaluate the role of HIV in the liver?
    • Blackard JT, Sherman KE. HCV/HIV co-infection: time to re-evaluate the role of HIV in the liver? J Viral Hepatitis 2008;15:323-330
    • (2008) J Viral Hepatitis , vol.15 , pp. 323-330
    • Blackard, J.T.1    Sherman, K.E.2
  • 8
    • 53549115066 scopus 로고    scopus 로고
    • Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis
    • Thien H, Yi Q, Dore G, et al. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008;22:1979-1991
    • (2008) AIDS , vol.22 , pp. 1979-1991
    • Thien, H.1    Yi, Q.2    Dore, G.3
  • 9
    • 0036829092 scopus 로고    scopus 로고
    • AGA technical review on nonalcoholic fatty liver disease
    • Sanyal A. AGA technical review on non-alcoholic fatty liver disease. Gastroenterology 2002;123:1705-1725 (Pubitemid 35231670)
    • (2002) Gastroenterology , vol.123 , Issue.5 , pp. 1705-1725
    • Sanyal, A.J.1
  • 13
    • 29244484291 scopus 로고    scopus 로고
    • Steatosis in chronic hepatitis C: Why does it really matter?
    • Asselah T, Rubia-Brandt L, Marcellin P, et al. Steatosis in chronic hepatitis C: why does it really matter? Gut 2006;55:123-130
    • (2006) Gut , vol.55 , pp. 123-130
    • Asselah, T.1    Rubia-Brandt, L.2    Marcellin, P.3
  • 14
    • 0034987263 scopus 로고    scopus 로고
    • Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
    • DOI 10.1053/jhep.2001.24432
    • Adinolfi Le, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and co-relates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-1364 (Pubitemid 32496971)
    • (2001) Hepatology , vol.33 , Issue.6 , pp. 1358-1364
    • Adinolfi, L.E.1    Gambardella, M.2    Andreana, A.3    Tripodi, M.-F.4    Utili, R.5    Ruggiero, G.6
  • 15
    • 1542287381 scopus 로고    scopus 로고
    • Hepatitis C Virus Infection and Diabetes: Direct Involvement of the Virus in the Development of Insulin Resistance
    • DOI 10.1053/j.gastro.2003.11.056
    • Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004;126:840-848 (Pubitemid 38298332)
    • (2004) Gastroenterology , vol.126 , Issue.3 , pp. 840-848
    • Shintani, Y.1    Fujie, H.2    Miyoshi, H.3    Tsutsumi, T.4    Tsukamoto, K.5    Kimura, S.6    Moriya, K.7    Koike, K.8
  • 17
    • 67449151649 scopus 로고    scopus 로고
    • The prevalence of metabolic syndrome in Danish patients with HIV infection: The effect of antiretroviral therapy
    • Hansen BR, Petersen J, Haugaard SB, et al. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. HIV Med 2009;10:378-387
    • (2009) HIV Med , vol.10 , pp. 378-387
    • Hansen, B.R.1    Petersen, J.2    Haugaard, S.B.3
  • 18
    • 11344293751 scopus 로고    scopus 로고
    • Cardiovascular risk and body-fat abnormalities in HIV-infected adults
    • DOI 10.1056/NEJMra041811
    • Grinspoon S, Carr A. Cardiovascular risk and body fat abnormalities in HIV-infected adults. N Engl J Med 2005;352:48-62. (Pubitemid 40075680)
    • (2005) New England Journal of Medicine , vol.352 , Issue.1 , pp. 48-62
    • Grinspoon, S.1    Carr, A.2
  • 19
    • 0042627763 scopus 로고    scopus 로고
    • The effect of HAART and HCV infection on the development of hyprglycaemia among HIV-infected persons
    • Mehta SH, Moore RD, Thomas DL, et al. The effect of HAART and HCV infection on the development of hyprglycaemia among HIV-infected persons. J AcquirImmune Defic Syndr 2003;33:577-584
    • (2003) J AcquirImmune Defic Syndr , vol.33 , pp. 577-584
    • Mehta, S.H.1    Moore, R.D.2    Thomas, D.L.3
  • 20
    • 48649085310 scopus 로고    scopus 로고
    • Incidence and risk factors for new-onset diabetes in HIV-infected patients. the data collection on adverse events of anti-HIV drugs (D.A.D) study
    • De-Wit S, Sabin C, Weber R, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients. The data collection on adverse events of anti-HIV drugs (D.A.D) study. Diabetes Care 2008;31:1224-1229
    • (2008) Diabetes Care , vol.31 , pp. 1224-1229
    • De-Wit, S.1    Sabin, C.2    Weber, R.3
  • 21
    • 0345064200 scopus 로고    scopus 로고
    • Data collection on adverse events of anti-HIV drugs (DAD) study group: Combination antiretroviral therapy and the risk of myocardial infarction
    • Fris-Moller N, Sabin C, Weber R, et al. Data collection on adverse events of anti-HIV drugs (DAD) study group: combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
    • (2003) N Engl J Med , vol.349 , pp. 1993-2003
    • Fris-Moller, N.1    Sabin, C.2    Weber, R.3
  • 22
    • 41249092708 scopus 로고    scopus 로고
    • HIV/HCV co-infection patients: Correlates, efficacy and outcomes of anti-HCV therapy
    • Rodriguez-Torres M, Govindarajan S, Sola R, et al. HIV/HCV co-infection patients: correlates, efficacy and outcomes of anti-HCV therapy. J Hepatol 2008;48:756-764.
    • (2008) J Hepatol , vol.48 , pp. 756-764
    • Rodriguez-Torres, M.1    Govindarajan, S.2    Sola, R.3
  • 23
    • 42249105690 scopus 로고    scopus 로고
    • Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection
    • Sterlin RK, Contos JM, Smith PG, et al. Steatohepatitis: risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2008;47:1118-1127
    • (2008) Hepatology , vol.47 , pp. 1118-1127
    • Sterlin, R.K.1    Contos, J.M.2    Smith, P.G.3
  • 24
    • 72549110354 scopus 로고    scopus 로고
    • Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients
    • Merchante N, Rivero A, de los Santos-Gil I, et al. Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients. Gut 2009;58:XX-XX.
    • (2009) Gut , vol.58
    • Merchante, N.1    Rivero, A.2    De Los Santos-Gil, I.3
  • 25
    • 68949205700 scopus 로고    scopus 로고
    • Insulin resistance is a major determinant of liver stiffness in non-diabetic patients with HCV genotype 1 chronic hepatitis
    • Petta S, Camma C, Di Marco V, et al. Insulin resistance is a major determinant of liver stiffness in non-diabetic patients with HCV genotype 1 chronic hepatitis. Aliment Pharmacol Ther 2009;30:603-613
    • (2009) Aliment Pharmacol Ther , vol.30 , pp. 603-613
    • Petta, S.1    Camma, C.2    Di Marco, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.